Journal article
Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial
Abstract
AIMS: Testosterone and its binding protein sex hormone-binding globulin have been associated with cardiovascular disease and dysglycaemia. However, information on the prognostic implication in patients at high cardiovascular risk with dysglycaemia is inconsistent. The study objective was to determine whether testosterone and/or sex hormone-binding globulin predict cardiovascular events or death in dysglycaemic patients.
METHODS: Dysglycaemic …
Authors
Wang A; Arver S; Boman K; Gerstein HC; Lee SF; Hess S; Rydén L; Mellbin LG
Journal
European Journal of Preventive Cardiology, Vol. 26, No. 8, pp. 847–854
Publisher
Oxford University Press (OUP)
Publication Date
5 2019
DOI
10.1177/2047487318819142
ISSN
2047-4873